1. Rich tapestry of G protein-coupled receptor signaling and regulatory mechanisms. Gurevich VV, Gurevich EV (2008) Mol Pharmacol 74(2): 312-6
    › Primary publication · 18515421 (PubMed) · PMC2865845 (PubMed Central)
  2. Opposing effects of inositol hexakisphosphate on rod arrestin and arrestin2 self-association. Hanson SM, Vishnivetskiy SA, Hubbell WL, Gurevich VV (2008) Biochemistry 47(3): 1070-5
    › Primary publication · 18161994 (PubMed) · PMC2562240 (PubMed Central)
  3. How and why do GPCRs dimerize? Gurevich VV, Gurevich EV (2008) Trends Pharmacol Sci 29(5): 234-40
    › Primary publication · 18384890 (PubMed) · PMC2652501 (PubMed Central)
  4. Haloperidol and clozapine differentially affect the expression of arrestins, receptor kinases, and extracellular signal-regulated kinase activation. Ahmed MR, Gurevich VV, Dalby KN, Benovic JL, Gurevich EV (2008) J Pharmacol Exp Ther 325(1): 276-83
    › Primary publication · 18178904 (PubMed) · PMC2629350 (PubMed Central)
  5. GPCR monomers and oligomers: it takes all kinds. Gurevich VV, Gurevich EV (2008) Trends Neurosci 31(2): 74-81
    › Primary publication · 18199492 (PubMed) · PMC2366802 (PubMed Central)
  6. Diffusion of the second messengers in the cytoplasm acts as a variability suppressor of the single photon response in vertebrate phototransduction. Bisegna P, Caruso G, Andreucci D, Shen L, Gurevich VV, Hamm HE, DiBenedetto E (2008) Biophys J 94(9): 3363-83
    › Primary publication · 18400950 (PubMed) · PMC2292384 (PubMed Central)
  7. Arrestins as multi-functional signaling adaptors. Gurevich VV, Gurevich EV, Cleghorn WM (2008) Handb Exp Pharmacol (186): 15-37
    › Primary publication · 18491047 (PubMed)
  8. Arrestins and two receptor kinases are upregulated in Parkinson's disease with dementia. Bychkov ER, Gurevich VV, Joyce JN, Benovic JL, Gurevich EV (2008) Neurobiol Aging 29(3): 379-96
    › Primary publication · 17125886 (PubMed) · PMC2275668 (PubMed Central)
  9. A model for the solution structure of the rod arrestin tetramer. Hanson SM, Dawson ES, Francis DJ, Van Eps N, Klug CS, Hubbell WL, Meiler J, Gurevich VV (2008) Structure 16(6): 924-34
    › Primary publication · 18547524 (PubMed) · PMC2464289 (PubMed Central)
  10. Altered expression and subcellular distribution of GRK subtypes in the dopamine-depleted rat basal ganglia is not normalized by l-DOPA treatment. Ahmed MR, Bychkov E, Gurevich VV, Benovic JL, Gurevich EV (2008) J Neurochem 104(6): 1622-36
    › Primary publication · 17996024 (PubMed) · PMC2628845 (PubMed Central)